167 related articles for article (PubMed ID: 6986631)
1. BCG, levamisole and transfer factor in the treatment of cancer.
Spitler LE
Prog Exp Tumor Res; 1980; 25():178-92. PubMed ID: 6986631
[No Abstract] [Full Text] [Related]
2. Immunotherapy of malignant melanoma.
Thiers BH
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):559-62. PubMed ID: 6176602
[No Abstract] [Full Text] [Related]
3. Immunotherapy from malignant disease.
Goodnight JE; Morton DL
Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
[No Abstract] [Full Text] [Related]
4. Immunotherapy of solid tumor.
Holmes EC
Surg Clin North Am; 1979 Apr; 59(2):371-80. PubMed ID: 375448
[No Abstract] [Full Text] [Related]
5. [Results of immunochemotherapy in malignant melanoma].
Duchková H; Richter J; Kubíková M; Peska J; Ragan J; Vohryzková E; Hrivnáková J; Kvasnicka J
Cesk Dermatol; 1980 Aug; 55(4):277-80. PubMed ID: 7407970
[No Abstract] [Full Text] [Related]
6. BCG as adjuvant immunotherapy for neoplasia.
Hersh EM; Gutterman JU; Mavligit GM
Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
[No Abstract] [Full Text] [Related]
7. Adjuvant therapy of cutaneous malignant melanoma: a critical review.
Koh HK; Sober AJ; Harmon DC; Lew RA; Carey RW
Med Pediatr Oncol; 1985; 13(5):244-60. PubMed ID: 3897817
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of superficial bladder cancer.
Shapiro A; Kadmon D; Catalona WJ; Ratliff TL
J Urol; 1982 Nov; 128(5):891-4. PubMed ID: 6184490
[No Abstract] [Full Text] [Related]
9. Immunotherapy of human cancer.
Hersh EM; Gutterman JU; Mavligit GM
Adv Intern Med; 1977; 22():145-85. PubMed ID: 65906
[No Abstract] [Full Text] [Related]
10. Adjuvant combination immunotherapy (BCG and levamisole) in malignant melanoma.
Dandapat MC; Mohapatra SK; Patra SK
Indian J Cancer; 1985 Jun; 22(2):100-7. PubMed ID: 3842124
[No Abstract] [Full Text] [Related]
11. Biologic response modifiers as adjuncts to other therapeutic modalities.
Borden EC; Hawkins MJ
Semin Oncol; 1986 Jun; 13(2):144-52. PubMed ID: 2424086
[No Abstract] [Full Text] [Related]
12. Immunotherapy of cancer: current status.
Goodnight JE; Morton DL
Prog Exp Tumor Res; 1980; 25():61-88. PubMed ID: 6986637
[No Abstract] [Full Text] [Related]
13. Immunotherapy of malignant melanoma.
Terry WD
N Engl J Med; 1980 Nov; 303(20):1174-5. PubMed ID: 6999351
[No Abstract] [Full Text] [Related]
14. Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors.
Knerich R; Robustelli della Cuna G; Butti G; Pavesi L; Adinolfi D; Preti P; Locatelli D
J Neurosurg Sci; 1985; 29(1):19-24. PubMed ID: 3906050
[TBL] [Abstract][Full Text] [Related]
15. Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
Mathe G
Comp Immunol Microbiol Infect Dis; 1980; 3(4):407-32. PubMed ID: 6451350
[No Abstract] [Full Text] [Related]
16. [Immunostimulation in the treatment of rheumatoid arthritis (author's transl)].
Rosenthal M
Schweiz Rundsch Med Prax; 1977 Nov; 66(45):1431-4. PubMed ID: 928307
[No Abstract] [Full Text] [Related]
17. Adjuvant immunotherapy.
Goodnight JE; Morton DL
Int Adv Surg Oncol; 1978; 1():53-83. PubMed ID: 399764
[TBL] [Abstract][Full Text] [Related]
18. Surgical adjuvant immunotherapy for lung cancer: a review.
Takita H
Curr Surg; 1984; 41(4):254-61. PubMed ID: 6383721
[No Abstract] [Full Text] [Related]
19. [Clinical trials of immunotherapy in lung cancer].
Budzyński W; Orłowski TM
Wiad Lek; 1984 Jul; 37(13):997-1003. PubMed ID: 6393588
[No Abstract] [Full Text] [Related]
20. Immunotherapy of lung cancer. I. Review of clinical trials in non-small cell histologic types.
Mikulski SM; McGuire WP; Louie AC; Chirigos MA; Muggia FM
Cancer Treat Rev; 1979 Sep; 6(3):177-90. PubMed ID: 394836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
